Svas Biosana SpA
MIL:SVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Svas Biosana SpA
MIL:SVS
|
IT |
Multiples-Based Value
The Multiples-Based Value for Svas Biosana SpA (SVS) under the Base Case is 17.56 EUR. Compared with the current market price of 9.1 EUR, the stock appears Undervalued by 48%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SVS Competitors Multiples
Svas Biosana SpA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IT |
S
|
Svas Biosana SpA
MIL:SVS
|
48.2m EUR | 0.4 | 7.1 | 3.5 | 5.2 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 10.3 | 37.6 | 27.2 | 32.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.8B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.4B CHF | 3.4 | 36.3 | 14 | 27.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
88.8B DKK | 3.3 | 22.8 | 12.2 | 14.6 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.8B USD | 3.2 | 31.1 | 13.5 | 18.5 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.8B USD | 1.1 | -16 | 17.2 | 55.6 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.1B GBP | 2.2 | 31.1 | 11 | 17.2 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
37.9B CNY | 8.3 | 23 | 20.6 | 20.6 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.3B CNY | 3.8 | 21.9 | 32.5 | 32.5 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.1T KRW | 95.7 | -36.5 | -81.6 | -77.4 |